CBU
LABU icon

CIBC Bancorp USA’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

CIBC Bancorp USA’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
4,750
+1,000
+27% +$191K ﹤0.01% 1023
2026
Q1 		$623K Buy
+3,750
New +$615K ﹤0.01% 1164

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CIBC Bancorp USA's LABU Position: Q2 2026 in Review

CIBC Bancorp USA increased its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 27% in Q2 2026, buying an estimated $191K and bringing the position to 4,750 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

CIBC Bancorp USA first reported a position in LABU in Q1 2026 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • CIBC Bancorp USA held 4,750 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $1.39M as of Q2 2026.
  • CIBC Bancorp USA bought 1,000 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $191K.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1023 holding.
  • CIBC Bancorp USA first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2026 and has held it in 2 quarters since.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.